Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With < em > KRAS < /em > < sup > G12C < /sup > -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review
CONCLUSION: Adagrasib may have a distinct hepatotoxicity profile from sotorasib and is more easily combined with CPIs either sequentially or concurrently. These differences may be used to inform clinical decisions regarding an initial KRASG12C inhibitor for patients who recently discontinued a CPI or experience hepatotoxicity on sotorasib.PMID:38579193 | DOI:10.1200/PO.23.00644 (Source: Ann Oncol)
Source: Ann Oncol - April 5, 2024 Category: Cancer & Oncology Authors: Jia Luo Narjust Florez Anjali Donnelly Yanyan Lou Kevin Lu Patrick C Ma Alexander I Spira Debra Ryan Hatim Husain Source Type: research
Identifying Genetic Loci Associated with an Increased Risk for Early Onset Colorectal Cancer
Ann Oncol. 2024 Apr 3:S0923-7534(24)00106-6. doi: 10.1016/j.annonc.2024.03.011. Online ahead of print.NO ABSTRACTPMID:38579969 | DOI:10.1016/j.annonc.2024.03.011 (Source: Ann Oncol)
Source: Ann Oncol - April 5, 2024 Category: Cancer & Oncology Authors: David Kelsen Irit Ben-Aharon Noa Gordon Source Type: research
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis
CONCLUSIONS: Due to the complexity of this patient population, close monitoring and multidisciplinary care are crucial. This approach is essential for effectively managing MM patients with renal dysfunction and for exploring novel treatment options.PMID:38576408 | DOI:10.1177/10781552241242022 (Source: Ann Oncol)
Source: Ann Oncol - April 5, 2024 Category: Cancer & Oncology Authors: Christy J Khouderchah Madeleine Ochs Matthew Pianko Zahra Mahmoudjafari Jordan Snyder Iman Ahmed Erica Campagnaro Victoria R Nachar Source Type: research
ASO Author Reflections: Advancing the Frontiers of Robotic Pancreaticoduodenectomy: Where are We Headed?
Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15241-9. Online ahead of print.NO ABSTRACTPMID:38573441 | DOI:10.1245/s10434-024-15241-9 (Source: Ann Oncol)
Source: Ann Oncol - April 4, 2024 Category: Cancer & Oncology Authors: Gurudutt P Varty Vikram A Chaudhari Shailesh V Shrikhande Manish S Bhandare Source Type: research
ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients
Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243-7. Online ahead of print.NO ABSTRACTPMID:38573442 | DOI:10.1245/s10434-024-15243-7 (Source: Ann Oncol)
Source: Ann Oncol - April 4, 2024 Category: Cancer & Oncology Authors: Junhong Liu Zhihua Shi Bingji Cao Zhe Wang Nan Zhang Junfeng Liu Source Type: research
ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial
Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15145-8. Online ahead of print.NO ABSTRACTPMID:38575722 | DOI:10.1245/s10434-024-15145-8 (Source: Ann Oncol)
Source: Ann Oncol - April 4, 2024 Category: Cancer & Oncology Authors: Thorsten O Goetze Alexander Reichart Ulli S Bankstahl Claudia Pauligk Maria Loose Thomas W Kraus Moustafa Elshafei Wolf O Bechstein J örg Trojan Matthias Behrend Nils Homann Marino Venerito Wolfram Bohle Michael Varvenne Claus Bolling Dirk M Behringer Ka Source Type: research
Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et al
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15240-w. Online ahead of print.NO ABSTRACTPMID:38568375 | DOI:10.1245/s10434-024-15240-w (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Amir Ashraf Ganjouei Jane Wang Adnan Alseidi Mohamed A Adam Source Type: research
Expanding Our Horizons: Editorial Comment on "The Effect of Laparoscopic Gastric Ischemic Preconditioning Prior to Esophagectomy on Anastomotic Stricture Rate with Comparison to Esophagectomy-Alone Controls"
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15238-4. Online ahead of print.NO ABSTRACTPMID:38568376 | DOI:10.1245/s10434-024-15238-4 (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Yoshitaka Ishikawa Source Type: research
Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium
CONCLUSIONS: The majority pN+ patients receive treatment within 12 months post-RP which was associated with high-risk pathological features and post-RP PSA. Variation in management of pN+ disease highlights the uncertainty regarding the optimal management. Understanding which patients will benefit from secondary treatment, and which type, will be critical to minimize variation in care.PMID:38570271 | DOI:10.1016/j.urolonc.2024.03.015 (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Daniel Triner Stephanie Daignault-Newton Udit Singhal Michael Sessine Robert T Dess Megan E V Caram Tudor Borza Kevin B Ginsburg Brian R Lane Todd M Morgan Michigan Urological Surgery Improvement Collaborative Source Type: research
BREAST-Q REACT: Qualitative Assessment of the Design, Functionality, and Clinical Utility of a New Score Interpretation Tool
CONCLUSION: Patients and providers in this qualitative study indicated that with some modifications, REACT has a great potential to elevate the clinical utility of the BREAST-Q by enhancing patient-provider communication that can lead to patient-centered, clinically relevant action recommendations based on longitudinal BREAST-Q scores.PMID:38570377 | DOI:10.1245/s10434-024-15185-0 (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Minji Kim Jaime L Gilliland Mei-Fan Parnes Cayla Bruce Carrie S Stern Robert J Allen Andrea L Pusic Audree B Tadros Jonas A Nelson Source Type: research
Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study
CONCLUSIONS: In patients with low-grade NMIBC, the urine microbiome undergoes changes over time after removal of the tumor. The microbiome detected in tumor tissues is more phylogenetically diverse than in paired urine samples collected at TURBT. The interplay between bladder microbiome, tumor microbiome, and their alterations requires further studies to elucidate their predictive value and perhaps therapeutic implications.PMID:38570378 | DOI:10.1245/s10434-024-15198-9 (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Aleksander Ślusarczyk Hamza Ismail Łukasz Zapała Tomasz Piecha Piotr Zapa ła Piotr Radziszewski Source Type: research
Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et al
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15240-w. Online ahead of print.NO ABSTRACTPMID:38568375 | DOI:10.1245/s10434-024-15240-w (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Amir Ashraf Ganjouei Jane Wang Adnan Alseidi Mohamed A Adam Source Type: research
Expanding Our Horizons: Editorial Comment on "The Effect of Laparoscopic Gastric Ischemic Preconditioning Prior to Esophagectomy on Anastomotic Stricture Rate with Comparison to Esophagectomy-Alone Controls"
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15238-4. Online ahead of print.NO ABSTRACTPMID:38568376 | DOI:10.1245/s10434-024-15238-4 (Source: Ann Oncol)
Source: Ann Oncol - April 3, 2024 Category: Cancer & Oncology Authors: Yoshitaka Ishikawa Source Type: research
ASO Author Reflections: Can We Evaluate Surgical Quality for Pancreatic Neuroendocrine Tumors?
Ann Surg Oncol. 2024 Apr 2. doi: 10.1245/s10434-024-15209-9. Online ahead of print.NO ABSTRACTPMID:38564069 | DOI:10.1245/s10434-024-15209-9 (Source: Ann Oncol)
Source: Ann Oncol - April 2, 2024 Category: Cancer & Oncology Authors: Francesca Fermi Stefano Partelli Massimo Falconi Source Type: research
ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer
Ann Surg Oncol. 2024 Apr 2. doi: 10.1245/s10434-024-15122-1. Online ahead of print.NO ABSTRACTPMID:38564070 | DOI:10.1245/s10434-024-15122-1 (Source: Ann Oncol)
Source: Ann Oncol - April 2, 2024 Category: Cancer & Oncology Authors: Minami Omura Takeo Kosaka Hiroaki Kobayashi Keisuke Shigeta Kazuhiro Matsumoto Satoshi Hara Eiji Kikuchi Shuji Mikami Hideyuki Saya Yasufumi Sato Mototsugu Oya Source Type: research
